aidsmap
@aidsmap
Followers
15K
Following
4K
Media
4K
Statuses
14K
aidsmap (previously known as NAM aidsmap) is now hosted by Terrence Higgins Trust, an HIV charity based in the United Kingdom.
United Kingdom
Joined June 2010
Our final news summary from #IAS2025 is out now incl:.-Does 6-monthly PrEP have a future after funding collapse?.-HIV integration sparks fierce debate .-US funding cuts & HIV testing/treatment.-Antibodies shows promise in the search for a cure.@iasociety
0
9
17
Non-Hodgkin lymphoma (NHL) is one of the two most common cancers in people living with HIV in the UK. The damage HIV does to the immune system makes people living with HIV more vulnerable to NHL than other people.
aidsmap.com
Non-Hodgkin lymphoma is one of the two most common cancers in people living with HIV in the UK.
0
3
3
News from #IAS2025: Is HIV integration a response or a death sentence? Communities demand answers @iasociety
2
3
8
News from #IAS2025: Does six-monthly PrEP have a future following the collapse of global HIV funding? @iasociety .
2
3
5
News from #IAS2025: Stepping into the AI-driven future of HIV prevention and care @iasociety .
0
5
6
News from #IAS2025: Children born with HIV have persistent inflammation markers linked to heart disease .@iasociety
2
1
7
Smoking is one of the most important causes of illness and death in HIV-positive people. For people with HIV who are undetectable, smoking has a much greater impact on life expectancy than HIV.
aidsmap.com
Smoking is one of the most important causes of illness and death in HIV-positive people. HIV-positive smokers have a greater risk of lung cancer
0
4
2
News from #IAS2025: The US cuts challenge African funders and governments to provide new models of PrEP access @iasociety .
0
2
5
News from #IAS2025: Conflicts and humanitarian crises create new HIV vulnerabilities @iasociety .
aidsmap.com
Garnering a standing ovation at IAS 2025, Sameer Sah, from Medical Aid for Palestinians, provided a devastating first-hand account of what’s been happening for nearly two years in Gazan healthcare...
2
4
7
News from #IAS2025: US funding cuts cause immediate drops in numbers testing and on HIV treatment @iasociety .
1
6
7
All anti-HIV drugs try to prevent HIV infecting new cells, but different types of drugs do it in different ways. Find out how treatment works on our illustrated page, or download it as a PDF leaflet
aidsmap.com
Easy-to-read and illustrated information on how different types of anti-HIV drugs work against HIV.
0
1
3
News from #IAS2025: Broadly neutralising antibodies plus immune modulator may delay HIV rebound @iasociety .
2
3
4
Our 2nd #IAS2025 news summary is out now, incl:.-Monthly oral PrEP pill .-Injectable ART works for people with adherence challenges.-ART switches don't reduce weight.-PEPFAR cuts & PrEP ..@iasociety
1
6
11
News from #IAS2025: Injectable HIV treatment works for people with poor HIV control in Africa @iasociety .
aidsmap.com
Injectable treatment with long-acting cabotegravir and rilpivirine is as effective as dolutegravir-based oral treatment in adults with HIV in sub-Saharan Africa who have a history of treatment...
0
2
3
News from #IAS2025: Lenacapavir and cabotegravir PrEP supported for use in pregnancy and breastfeeding @iasociety .
0
4
6
RT @iasociety: "The theme of #AIDS2026 is Rethink. Rebuild. Rise (#RethinkRebuildRise):. #Rethink what leadership looks like. #Rebuild the….
0
15
0
News from #IAS2025: Intermittent HIV treatment dosing may be a response to the funding crisis, but adolescent study raises concerns @iasociety .
2
4
10
News from #IAS2025: Scaling back PEPFAR will leave 700,000 without PrEP and cause 6700 new HIV infections within a year @iasociety .
0
4
8
Want to keep up to date with the latest HIV news?.Subscribe to aidsmap bulletins and we'll share HIV research and developments from around the world and news from international HIV conferences.
0
1
0
